Zdravka Pashova-Tasseva

Dr. Zdravka Pashova-Tasseva

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2025 in Nanomaterials
Verified
Journal Article
Open access
PDF file
AMAntoaneta M. Mlachkova
Antoaneta M. Mlachkova
VDVelitchka Dosseva-Panova
Velitchka Dosseva-Panova
HMHristina Maynalovska
Hristina Maynalovska
Zdravka Pashova-TassevaZdravka Pashova-Tasseva
Zdravka Pashova-Tasseva
Periodontitis is a widespread disease, associated with challenges both in its diagnosis and in selecting from various therapeutic approaches, which do not always yield the expected success. This literature review was conducted to explore diverse therapeutic approaches, especially those focused on nanotechnologies, and their potential contribution to the successful modulation of the host’s response. The effects of the existing microbial diversity and the imbalance of key microbial species in contributing to the progression and worsening of the host’s response in periodontitis are well known. It is essential to understand the role of a well-structured treatment plan for periodontitis, providing opportunities for new research and innovative treatment strategies aimed at reducing the impact of periodontitis on oral and overall systemic health. This will be beneficial for dental professionals, enabling them to effectively prevent and treat periodontitis, ultimately improving the overall health and well-being of patients.

30 June 2023 in Folia Medica
Verified
Journal Article
Open access
PDF file
Zdravka Pashova-TassevaZdravka Pashova-Tasseva
Zdravka Pashova-Tasseva
AMAntoaneta Mlachkova
Antoaneta Mlachkova
ETEkaterina Tosheva
Ekaterina Tosheva
Aim: The aims of the present study were to explore the relations between the gingival phenotype (GP) and the periodontal health status and find the prevalence of a specific gingival phenotype in a small Bulgarian population. Materials and methods: We recruited 50 patients attending our dental practice with different periodontal diagnoses. A detailed periodontal status was taken to assess the diagnosis of each participant. Several clinical methods for evaluation of the gingival thickness and keratinized tissue width, including the TRAN method, transgingival probing, and direct measurement, were used. The data were summarized and analyzed statistically. Results: We found a significant prevalence of the thick gingival phenotype, in particular the thick flat type. The patients with periodontitis had a higher distribution of the thick gingival phenotype, while in those with gingivitis, the thin scalloped gingival phenotype was noted. In regards to the gingival thickness (GT), 36 participants were found to have GT >1 mm, and the remaining 14 had GT ≤1 mm. Statistically significant differences were found in the keratinized tissue width and the width of attached gingiva in the different gingival phenotypes. No significant differences were found in the age and sex of participants. Conclusions: We found a significant prevalence of the thick (with a mild prevalence of thick flat to thick scalloped) versus thin gingival phenotype in the studied sample. The highest relative proportion of patients with periodontitis was among the subsample of individuals with thick flat gingival phenotype. Regarding gingivitis, the highest proportion was in the thin scalloped phenotype subsample – 42.9%. The highest prevalence of periodontal health was among the individuals with thick scalloped GP (50%), followed by the thin scalloped GP (35.7%).

18 September 2024 in Genes
Verified
Journal Article
Open access
PDF file
Zdravka Pashova-TassevaZdravka Pashova-Tasseva
Zdravka Pashova-Tasseva
VDVelitchka Dosseva-Panova
Velitchka Dosseva-Panova
AMAntoaneta M. Mlachkova
Antoaneta M. Mlachkova
ASAlexey Savov
Alexey Savov
ETEkaterina Alexandrova Tosheva
Ekaterina Alexandrova Tosheva
Background: Periodontitis is a complex disease, and bacterial factors play a crucial role in its initiation. The contributions of genetic and epigenetic factors to the pathogenesis of periodontal disease are increasingly recognized. Single-nucleotide polymorphisms (SNPs) in various molecules, including cytokines, are of particular interest due to their established involvement in numerous diseases. This study investigates the influence of SNPs in the IL-10 gene at positions −592 (rs1800872) C>A and −1082 (rs1800896) T>C (also referred to as 1082A>G) on the severity of periodontitis in a cohort of Bulgarian patients. Methods: In the recent study, both clinical and paraclinical methodologies were employed to comprehensively assess the periodontal status of the participants. The genotypic characterization of IL-10 polymorphisms was performed by PCR RFLP analysis. Statistical analyses, including principal component analysis (PCA), were executed utilizing IBM SPSS Statistics Version 21. Results: We have established a statistically significant association between the presence of at least one A-allele in the patients’ genotype and the incidence of severe periodontitis (p = 0.047). Conclusions: IL-10 single-nucleotide polymorphisms (SNPs) could be effectively considered as biomarkers for the severity of periodontitis.

28 July 2025 in Genes
Verified
Journal Article
Open access
PDF file
Zdravka Pashova-TassevaZdravka Pashova-Tasseva
Zdravka Pashova-Tasseva
AMAntoaneta M. Mlachkova
Antoaneta M. Mlachkova
Kamen KotsilkovKamen Kotsilkov
Kamen Kotsilkov
HMHristina Maynalovska
Hristina Maynalovska
Periodontitis is a prevalent chronic inflammatory disease with complex etiopathogenesis involving microbial dysbiosis, host immune response, environmental factors, and genetic susceptibility. Among the cytokines implicated in periodontal immunoregulation, interleukin-35 (IL-35) has emerged as a novel anti-inflammatory mediator with potential diagnostic and therapeutic relevance. This narrative review evaluates the role of IL-35 in periodontal disease by exploring its local and systemic expression, response to non-surgical periodontal therapy (NSPT), and association with clinical disease severity. Additionally, current evidence regarding IL-35 gene polymorphisms and their potential contribution to individual susceptibility and disease progression, as well as their relevance in related systemic conditions, is assessed. A comprehensive review and synthesis of recent clinical and experimental studies were conducted, focusing on IL-35 levels in saliva, serum, and gingival crevicular fluid (GCF) among patients with healthy periodontium, gingivitis, and various stages of periodontitis, both before and after NSPT. Emphasis was placed on longitudinal studies evaluating IL-35 dynamics in correlation with periodontal parameters, as well as genetic association studies investigating IL-12A and EBI3 gene polymorphisms. IL-35 levels were generally found to be higher in healthy individuals and reduced in periodontitis patients, indicating a possible protective role in maintaining periodontal homeostasis. Following NSPT, IL-35 levels significantly increased, corresponding with clinical improvement and reduced inflammatory burden. Genetic studies revealed variable associations between IL-35 polymorphisms and susceptibility to periodontitis and related systemic conditions, although further research is needed for validation. IL-35 appears to function as a modulator of immune resolution in periodontal disease, with potential utility as a non-invasive biomarker for disease activity and therapeutic response. Its upregulation during periodontal healing supports its role in promoting tissue stabilization. The integration of cytokine profiling and genetic screening may enhance personalized risk assessment and targeted interventions in periodontal care.

4 September 2025 in Cancers
Verified
Journal Article
Open access
PDF file
EDElitsa Deliverska
Elitsa Deliverska
VRVessela Raykova
Vessela Raykova
SYStanislav Yordanov
Stanislav Yordanov
DMDaniel Markov
Daniel Markov
SSSvetoslav Slavkov
Svetoslav Slavkov
Zdravka Pashova-TassevaZdravka Pashova-Tasseva
Zdravka Pashova-Tasseva
Background/Objectives: Head and neck squamous cell carcinoma (NHSCC) is a significant global health burden, with human papillomavirus (HPV) recognized as a major etiological factor in a growing proportion of cases. The interaction between HPV status, tumor characteristics, and other risk factors remains an important focus for both prevention and clinical management. This study aimed to investigate the association between HPV and OPSCC in a Bulgarian cohort, with emphasis on the influence of behavioral and clinical factors, as well as basic tumor features. Methods: Eighty-nine participants were enrolled, including 50 patients with histologically confirmed NHSCC and 39 healthy controls. Clinical examinations and histopathological verification were conducted for all cases. Brush smear and oral rinse samples were collected for HPV testing, in line with molecular detection protocols, specifically PCR-based assays for viral DNA. Demographic data, behavioral risk factors, and information on concomitant diseases were obtained and analyzed in relation to HPV status. Results: Differences were identified between HPV-positive and HPV-negative NHSCC cases in relation to tumor characteristics, including clinical presentation and histological differentiation. Additional analyses demonstrated associations between certain behavioral factors, comorbidities, and the risk of NHSCC. Conclusions: This study provides data on HPV prevalence, related tumor features, and associated risk factors in OPSCC within a Bulgarian population. These findings highlight descriptive trends related to HPV status but indicate no robust statistical associations in this cohort.

8 September 2022 in Biotechnology & Biotechnological Equipment
Verified
Journal Article
Open access
VDVelitchka Dosseva-Panova
Velitchka Dosseva-Panova
Zdravka Pashova-TassevaZdravka Pashova-Tasseva
Zdravka Pashova-Tasseva
AMAntoaneta Mlachkova
Antoaneta Mlachkova
The association between the periodontal conditions and smoking is attracting increasing attention. There is little information about the significance of the gene expression levels of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) for the severity of attachment loss in patients with smoking habits. The aim of this study was to evaluate the relationship between the severity of periodontitis and the gene expression levels of IL-6 and TNF-α in the presence of a main risk factor – smoking. A total of 20 individuals (periodontitis patients) participated in this study. The following clinical parameters were studied: hygiene index, gingival bleeding index, probing depth, clinical attachment loss, furcation involvement and tooth mobility, in patients of mean age of 50.25 ± 8.45 years with untreated periodontitis. Gingival biopsies were taken adjacent to shallow ( 6 mm) periodontal pockets and similar attachment loss for Real-Time polymerase chain reaction (PCR) assessment of IL-6 and TNF-α gene expression levels. The obtained results demonstrated higher values for attachment loss and periodontal pocket depth in the presence of smoking. Furthermore, the results indicated smoking as an important risk factor which could greatly influence the studied gene expression levels. Smoking affected the gene expression mainly in conjunction with deep periodontal pockets. Our results suggest that smoking is an important risk factor for attachment loss in periodontitis patients demonstrated by clinical measurements and IL-6 and TNF-α gene expression.